#Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast

[mitalipingale]

https://tannda.net/read-blog/73424_digital-pcr-dpcr-and-real-time-pcr-qpcr-market-share-overview-competitive-analys.html

The Digital PCR (dPCR) and Real-time PCR (qPCR) Market in 2023 is US$ 8.5 billion, and is expected to reach US$ 15.76 billion by 2031 at a CAGR of 8.00%.

[skyquest-market-research]

Why Investors Are Eyeing the dPCR and qPCR Market for Growth Opportunities

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is experiencing robust growth as advancements in molecular diagnostics and biotechnology revolutionize the healthcare and research sectors. According to a comprehensive analysis by SkyQuest Technology, the market is projected to reach unprecedented heights, reflecting a compound annual growth rate (CAGR) of 8.1% during the forecast period. As these technologies gain prominence, industries worldwide are embracing their potential for precision diagnostics, disease monitoring, and scientific breakthroughs.

Market Size and Growth Projections

The global digital PCR (dPCR) and real-time PCR (qPCR) market is thriving due to the surge in demand for advanced diagnostic tools. With a market value estimated at USD 10.1 billion in 2023, it is anticipated to achieve a value of USD 20.36 billion by 2032. This substantial growth is attributed to the increasing prevalence of infectious diseases, rising cancer cases, and a growing focus on personalized medicine.

Request a Sample of the Report here: https://www.skyquestt.com/sample-request/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Key Market Drivers

The growth of the dPCR and qPCR market is influenced by several factors, including:

Rising Demand for Molecular Diagnostics With a greater emphasis on early detection and precision, the demand for molecular diagnostic tools is skyrocketing. dPCR and qPCR technologies enable highly sensitive and accurate analysis of genetic material, making them indispensable in diagnosing critical illnesses.

Advancements in Technology Continuous innovation in PCR technologies is leading to faster, more accurate, and cost-effective solutions, enhancing their adoption across various industries.

Applications in Research and Development The increasing focus on drug development and genetic research has further expanded the utility of dPCR and qPCR technologies in laboratories worldwide.

Market Segments

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is categorized based on technology, application, and end-user.

By Technology

Digital PCR (dPCR)

Real-Time PCR (qPCR)

By Application

Clinical Diagnostics

Research and Development

Forensic Applications

By End-User

Hospitals and Diagnostic Centers

Research Institutes

Biotech and Pharmaceutical Companies

Request a Customized Report Tailored to Your Needs: https://www.skyquestt.com/customization/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Regional Insights

The adoption of dPCR and qPCR technologies varies across regions, with distinct trends shaping the global market.

North America A dominant market due to advanced healthcare infrastructure, extensive research funding, and early adoption of innovative technologies.

Europe Strong emphasis on biotechnology and personalized medicine drives the market in countries like Germany, France, and the UK.

Asia-Pacific The fastest-growing region, fueled by the increasing prevalence of chronic diseases, expanding research activities, and government initiatives to enhance healthcare systems.

Latin America & Middle East Emerging markets show steady growth due to improving healthcare access and rising investments in diagnostic technologies.

Buy the Report to Get the Full Analysis: https://www.skyquestt.com/buy-now/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Top Players in the Market

The dPCR and qPCR market is highly competitive, with key players driving innovation and growth:

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

Roche Diagnostics

QIAGEN N.V.

Agilent Technologies

Merck KGaA

Takara Bio Inc.

Promega Corporation

Illumina, Inc.

Fluidigm Corporation

View full ToC and List of Companies here: https://www.skyquestt.com/report/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Emerging Trends in the dPCR and qPCR Market

Increased Focus on Point-of-Care Diagnostics Portable and user-friendly devices are making molecular diagnostics accessible even in resource-limited settings.

Integration of AI and Big Data Advanced analytics are enhancing the accuracy and efficiency of PCR technologies, paving the way for groundbreaking discoveries.

Growth in Personalized Medicine With a shift towards tailored treatments, dPCR and qPCR technologies are playing a pivotal role in identifying genetic markers and designing customized therapies.

Expansion of Applications Beyond Healthcare The utility of these technologies is extending into food safety, agriculture, and environmental monitoring, further diversifying market opportunities.

Conclusion

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is set to transform diagnostics and research on a global scale. As technological innovations continue to enhance the precision and accessibility of these tools, the market offers promising opportunities for growth across diverse sectors. Companies focusing on innovation, adaptability, and application expansion are poised to lead in this rapidly evolving industry.

[heathcareforallworld]

Trends and Projections for the Taq DNA Polymerase Market

The Taq DNA Polymerase Market is witnessing significant growth due to the increasing demand for polymerase chain reaction (PCR) technologies in various fields such as medical diagnostics, biotechnology, and forensic science. As the backbone of PCR, Taq DNA polymerase is indispensable for amplifying DNA sequences, making it a crucial component in research and clinical laboratories worldwide. This article delves into the market size, share, industry trends, and forecasts for the Taq DNA polymerase market through 2032.

Market Overview

Taq DNA polymerase is a thermostable enzyme extracted from the bacterium Thermus aquaticus, which is capable of withstanding high temperatures required for PCR. This enzyme's ability to replicate DNA sequences efficiently and accurately under thermal cycling conditions has revolutionized molecular biology and genetic research.

Market Size and Share

Taq dna polymerase Market Size was estimated at 1.6 (USD Billion) in 2023. The Taq Dna Polymerase Market Industry is expected to grow from 1.69(USD Billion) in 2024 to 2.53 (USD Billion) by 2032. The taq dna polymerase Market CAGR (growth rate) is expected to be around 5.19% during the forecast period (2024 - 2032).

North America currently holds the largest market share, accounting for over 40% of the global market. This dominance is attributed to the region's well-established biotechnology and pharmaceutical industries, extensive research activities, and the presence of key market players. Europe follows closely, with significant contributions from countries like Germany, the UK, and France. The Asia-Pacific region is expected to witness the fastest growth, driven by increasing investments in biotechnology, rising healthcare expenditure, and growing awareness about molecular diagnostics.

Industry Trends

Technological Advancements: The Taq DNA polymerase market is benefiting from continuous technological innovations. The development of high-fidelity and fast-cycling Taq polymerases has enhanced the efficiency and accuracy of PCR, expanding its applications in various fields.

Rising Demand for Molecular Diagnostics: The increasing prevalence of infectious diseases, genetic disorders, and cancer has fueled the demand for molecular diagnostics. Taq DNA polymerase plays a crucial role in diagnostic assays, including COVID-19 testing, driving market growth.

Expansion of Personalized Medicine: The shift towards personalized medicine, which relies on genetic profiling for tailored treatments, is boosting the demand for Taq DNA polymerase. PCR-based techniques are integral to genetic testing and the development of personalized therapies.

Growing Research and Development Activities: The surge in research and development activities in genomics, proteomics, and biotechnology is propelling the demand for Taq DNA polymerase. Government and private sector investments in research are further stimulating market growth.

Increased Forensic Applications: The application of PCR in forensic science for DNA profiling and criminal investigations is expanding. Taq DNA polymerase is a vital tool in forensic labs, aiding in the accurate identification of individuals from biological samples.

Market Drivers

Advancements in PCR Technology: Innovations such as real-time PCR (qPCR) and digital PCR (dPCR) are driving the adoption of Taq DNA polymerase. These advanced techniques offer higher sensitivity, specificity, and quantification capabilities, broadening the scope of PCR applications.

Growing Biotechnology Industry: The biotechnology industry's rapid growth, coupled with increasing investments in genetic research, is boosting the demand for Taq DNA polymerase. The enzyme is essential for various applications, including cloning, sequencing, and gene expression analysis.

Increasing Prevalence of Genetic Disorders: The rising incidence of genetic disorders and the need for early diagnosis and treatment are driving the demand for PCR-based diagnostic tests. Taq DNA polymerase is a key component in these tests, contributing to market growth.

COVID-19 Pandemic: The COVID-19 pandemic has significantly increased the demand for PCR testing, highlighting the importance of Taq DNA polymerase. The enzyme's critical role in detecting the virus has led to a surge in production and sales.

Challenges

High Cost of Enzyme Production: The production of high-quality Taq DNA polymerase involves complex processes and significant investment, leading to high costs. This can be a barrier for small-scale laboratories and research institutions.

Competition from Alternative Enzymes: The market faces competition from alternative DNA polymerases with improved properties, such as higher fidelity and faster cycling times. The development and adoption of these alternatives can impact the market share of Taq DNA polymerase.

Stringent Regulatory Requirements: The stringent regulatory requirements for the approval and commercialization of diagnostic and research products can pose challenges for market players. Compliance with these regulations can be time-consuming and costly.

Market Forecast (2024-2032)

The Taq DNA polymerase market is poised for substantial growth over the forecast period. Key factors contributing to this growth include:

Expanding Applications in Diagnostics and Research: The ongoing advancements in PCR technology and the expanding applications in diagnostics and research are expected to drive market growth. The enzyme's versatility and reliability make it indispensable in various fields.

Increasing Investments in Biotechnology: The increasing investments in biotechnology and genetic research by governments, private companies, and research institutions will propel the demand for Taq DNA polymerase. The enzyme's role in groundbreaking research and development activities will continue to drive market expansion.

Emerging Markets in Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare expenditure, increasing biotechnology investments, and growing awareness about molecular diagnostics. Countries like China, India, and Japan are key markets to watch.

Adoption of Personalized Medicine: The shift towards personalized medicine and the growing demand for genetic testing will boost the market for Taq DNA polymerase. The enzyme's critical role in genetic analysis and the development of personalized therapies will drive its adoption.

Conclusion

The Taq DNA polymerase market is on a robust growth trajectory, driven by technological advancements, increasing demand for molecular diagnostics, and expanding research and development activities. Key players in the industry are focusing on product development, strategic collaborations, and expanding their geographical presence to capitalize on the growing demand for Taq DNA polymerase.

[soumyafwr]

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Analysis and Forecast 2031

[research-89]

https://writeupcafe.com/digital-pcr-dpcr-and-real-time-pcr-qpcr-market-overview-size-share-and-forecast-2031/

[delvenservices]

PCR Technologies Market Analysis by Application, Technology, End User & Geography

PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), End user (Academia, pharma-biotech, applied) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa and South America)

Market Overview

The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.8 billion in 2021, at a CAGR of 6.3% from 2020 to 2028.

Continuous technological advancements in PCR technologies, Target diseases and genetic disorders; the development of miniaturized portable instruments, and incorporation of robotics; increasing investments, funds, and grants for research activities; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project are some of the factors that have supported long-term expansion for PCR Technologies Market.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/pcr-technologies-market-trends-forecast-till-2028

Key Findings

PCR Technologies Market is segmented into technique, product type, application, end-user, and geography.

The technique segment is segmented into conventional PCR, real-time PCR, digital PCR, reverse transcription PCR, hot-start PCR, and multiplex PCR.

The product type segment is segmented into instruments, reagents & consumables, and software & services.

The application segment is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid detection, nucleic acid synthesis, standard validation/verification, diagnostic applications, and environmental applications.

Geographically, PCR Technologies Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East, and Africa, and South America and insights are provided for each region and major countries within the regions

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/pcr-technologies-market-trends-forecast-till-2028

Competitive Landscape

Key players in PCR Technologies Market are

Thermo Fisher Scientific, Inc. (US),

F. Hoffman-La Roche Ltd. (Switzerland),

Bio-Rad Laboratories, Inc. (US),

QIAGEN N.V. (Germany),

Takara Bio, Inc. (Japan),

Agilent Technologies, Inc. (the US),

bioMérieux S.A. (France),

Fluidigm Corporation (US),

Danaher Corporation (US),

Abbott Laboratories (US),

Merck KGaA (Germany),

Becton Dickinson and Company (US),

Promega Corporation (US),

Eppendorf AG (Germany),

Analytik Jena AG (Germany).

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors

Gain authentic and granular data access for PCR Technologies market to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Get the Direct Order for the Report: https://www.delvens.com/checkout/pcr-technologies-market-trends-forecast-till-2028

The PCR Technologies Market report answers a number of crucial questions, including:

Which companies dominate the PCR Technologies Market?

What current trends will influence the market over the next few years?

 What are the market's opportunities, obstacles, and driving forces?

What predictions for the future can help with strategic decision-making?

What advantages does market research offer businesses?

Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?

What is the anticipated growth rate for the market economy globally?

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

Read More from Delvens:

[hustler0101]

This report studies the Real-time PCR (qPCR) and Digital PCR (dPCR) market size (value and volume) by players, regions, product types and end industries, history data 2018-2022 and forecast data 2023-2030; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

[marketresearchnews1242]

Global Digital PCR Market Competitions From Opponents Research 2022

The healthcare vertical is witnessing an ever-increasing need for automation, thereby leading to quick service provision for bridging existential gap between medical professionals and users. One of the most profit-making healthcare technologies is Artificial Intelligence, which enables automated service provision. The application areas include collection, management, and processing a huge quantity of user data. This would be the behaviour of the Digital PCR Market in the forecast period. Digital PCR Market Share, Growth, Trends And Forecast To 2031| value of US$ 347 Mn at a CAGR of 9.3%

The global digital PCR market is worth more than US$ 132 Mn at present. Demand for digital PCR is estimated to surge at a CAGR of 9.3% with an estimated value of US$ 347 Mn by 2031. User-friendly instruments of digital PCR, novel applications of digital PCR, and automation in advanced digital PCR instruments are some of the key trends in the market.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/20476

Digital PCR, or dPCR, is a new quantitative PCR method that enables ultrasensitive and reproducible detection as well as quantification of nucleic acid. It is an alternative method to conventional real-time qPCR, where the amplification reaction remains same but the method of quantifying the target sample differs.

Rising awareness about advanced molecular diagnostics is set to enhance the utilization of dPCR. Molecular diagnostics, specifically nucleic acid-based techniques for the detection of infectious diseases are rapidly growing approaches in clinical diagnostic laboratories. These techniques have been evolving since their development, including advances in digital PCR technologies that can now aid in the precise diagnosis of life-threatening diseases such as cancer and Ebola. There are several digital PCR-based diagnostic kits and assays for multiple diseases that have been introduced in molecular diagnosis over the previous decade.

Increasing global funding in research & development is adjacent to driving the demand of digital PCRs. Application of PCR-based techniques in drug discovery, genomics, and personalized medicine has augmented its penetration to reach the field of point-of-care molecular diagnostics. To address the global disease burden, there is a recent surge in the expenditure that contributes to the research and development of disease-related scientific studies. The trend is also encouraging molecular diagnostic manufacturers to invest more and support ongoing research in government and non-profit organizations.

Additionally, the National Institute of Health (NIH) has started the precision medicine initiative to address the issues and time associated with disease diagnosis and treatment. As opposed to the ‘one-size-fits-all’ treatment approach, precision medicine is an innovative approach that considers variety in people’s genes, environments, and lifestyles. Implementation of precision medicine has led to new discoveries and several FDA approvals for treatments pertaining to specific characteristics of an individual.

Company Profiles:

Bio-Rad Laboratories, Inc.

Agilent Technologies

Thermo Fisher Scientific Inc.

Fluidigm Corp

Formulatrix, Inc

JN Medsys

ADJUST

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/20476

Key Takeaways from Market Study

By product, instruments are expected to hold over 70% market value share by the end of 2031, primarily because of the presence of key market players for production worldwide.

Based on application, basic research is leading with nearly 35% market share, owing to extensive research opportunities in infection diagnosis and drug discovery.

Research institutes dominated the end-user segment with a share of around 69.4% in 2020, due to increasing number of molecular biology companies focusing on infection diagnostics after the COVID-19 pandemic.

By region, North America is slated to be the largest market with a value share of 35% by the end of the forecast period (2021 to 2031).

“Advancements in technology and application of digital PCR in drug discovery are anticipated to propel demand for as a measure for disease detection and prevention,” says an analyst of Persistence Market Research.

Market Competition

Acquisitions, mergers, expansions, and product launches are the key strategies adopted by manufacturers to increase their consumer base across geographies.

On October 28, 2021, Bio-Rad Laboratories projected a growth rise in Q3 revenue after acquisition of dPCR maker, Dropworks.

On September 20, 2021, Thermofisher launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

On January 14, 2019, Qiagen NV agreed to acquire certain molecular testing assets from Formulatrix Inc., including the CONSTELLATION® series of instruments.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the digital PCR market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the product (instruments, consumables, and service), application (clinical diagnostics, basic research, applied research, and forensic testing), and end user (pharmaceutical companies, research institutes, forensic labs and agriculture companies), across seven key regions of the world.

Key geographies evaluated in this report are: North America – U.S, Canada Europe – France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS APAC – China, India, Japan, Australia, Others Latin America – Argentina, Brazil, Others

Access Full Report@ https://www.persistencemarketresearch.com/checkout/20476

Key Questions Answered in This Report.

What will the Market growth rate in Future?

What are the key factors driving the global Market?

Who are the key manufacturers in Market space?

What are the opportunities and threats faced by the vendors in the global industry?

What are sales, revenue, and price analysis by regions of industry?

About Us: Persistence Market Research

Contact Us:

Persistence Market Research           Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – sales@persistencemarketresearch.com

[balrajgis]

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Demand, Overview, Size, Trend | Thermo Fisher Scientific, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd.

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market report from Global Insight Services is the single authoritative source of intelligence on Digital PCR (dPCR) and Real-time PCR (qPCR) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Polymerase chain reaction (PCR) is a method used to amplify a specific region of DNA. The DNA is first denatured into single strands, and then primers have added that bind to the target region. The DNA is then amplified using a thermostable DNA polymerase. PCR can be used to amplify a specific region of DNA, or it can be used to generate large quantities of a specific DNA sequence.

Get Free Sample Copy of This Report – https://www.globalinsightservices.com/request-sample/GIS20471/

Key Trends

Digital PCR (dPCR) and Real-time PCR (qPCR) technology are two of the most popular methods for PCR. dPCR is a newer technology that is becoming increasingly popular due to its higher accuracy and precision. qPCR is still the most widely used method due to its ease of use and lower cost.

Some of the key trends in dPCR and qPCR technology include:

– Increased accuracy and precision: dPCR is more accurate and precise than qPCR, making it the preferred method for many applications.

Key Drivers

Digital PCR (dPCR) and Real-time PCR (qPCR) are two of the most popular methods for PCR-based detection of nucleic acids. Both methods are highly sensitive and specific, and can be used for a variety of applications including gene expression analysis, pathogen detection, and genotyping. dPCR is typically more sensitive than qPCR, due to the fact that dPCR can quantify absolute copy numbers of target sequences, while qPCR can only relative copy numbers. In addition, dPCR is not affected by PCR inhibitors, while qPCR can be.

Market Segmentation 

By Technology 

Quantitative

Digital

By Product 

Consumables & Reagents

Instruments

By Application 

Clinical

Research

By Region:

North AmericaThe U.S.

Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS20471

Key Players

Thermo Fisher Scientific

Bio-Rad Laboratories Inc.

F. Hoffmann-La Roche, Ltd.

Abbott Laboratories

Agilent Technologies

Analytik Jena AG

Becton Dickson and Company

BioMerieux SA

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[rahulg1122]

Future Growth Analysis of Neurodiagnostics Market

According to the new market research report "Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User, and Region - Global Forecast to 2024", published by MarketsandMarkets™, the Neurodiagnostics Market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%.

Browse in-depth TOC on "Neurodiagnostics Market"

189 – Tables

28 – Figures  

239 – Pages 

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229090425

The demand for neurodiagnostic products is expected to grow mainly due to factors such as the increasing prevalence of neurological disorders & diseases, technological advancements, growing patient emphasis on effective & early disease diagnosis, the growing number of diagnostic centers & hospitals, and the use of biomarker profiling for disease diagnostics. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.

The diagnostic imaging systems segment accounted for the largest share of the Neurodiagnostics Market, by product, in 2018.

Based on the product, the market is segmented into diagnostic imaging systems, clinical diagnostic instruments, and reagents and consumables. The diagnostic imaging systems segment accounted for the largest share of the market in 2018. The increasing incidence and prevalence of neurological disorders and growing R&D in the field of cerebral and spinal disorders are the major factors driving the growth of this segment.

The hospitals & surgical centers segment accounted for the largest share of the Neurodiagnostics Market, by end-user, in 2018

On the basis of end-user, the market is segmented into hospitals & surgical centers, diagnostic laboratories & imaging centers, neurology centers, ambulatory care centers (ACCs), and research laboratories & academic institutes.

In 2018, hospitals & surgical centers accounted for the largest share of the Neurodiagnostics Market, mainly due to the financial capabilities of hospitals to purchase expensive equipment, such as neurodiagnostic devices.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=229090425

North America accounted for the largest share of the Neurodiagnostics Market in 2018

North America accounted for the largest share of the market in 2018, followed by Europe. This can primarily be attributed to the presence of a highly developed healthcare system, high adoption of innovative neurodiagnostic devices among medical professionals, and the full availability of advanced neurodiagnostic devices.

Some of the prominent players in the Neurodiagnostics Market include GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).

Browse Related Reports:

Next-generation Sequencing Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024

[techscimarketresearch]

Product Review: Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 | TechSci Research

The application of a real-time Polymerase chain reaction (PCR) system in the field of molecular diagnostics has become a standard method for identifying nucleic acids from collected microbial samples. The real-time PCR (also known as RT-PCR) systems are sensitive, rapid, precise, and minimize the risk of contamination while being employed for various research procedures such as detection and expression analysis of genes, quantitative genotyping, early diagnosis of diseases, forensics, etc. Ever since the introduction of RT-PCR, the technology is just getting better with each medical innovation. The COVID-19 pandemic has put RT-PCR in the spotlight as it is considered the most accurate and efficient testing method for the detection of the SARS-CoV-2 virus. The use of RT-PCRs has been tremendously expanding for the testing of novel coronavirus and the demand is likely to grow due to the rising incidences of infectious diseases.

Recently, Bio-Rad Laboratories introduced the next generation of the company's CFX real-time PCR systems, CFX Opus 96 and CFX Opus 384, that offers improved connectivity and high performance. The sleek and modern CFX systems bring forth the next revolution in qPCR with their easy-to-use interface and advanced connectivity options. Both the RT-PCR systems are ideal for basic and translational research, genomic testing, quality control, process development, detecting infectious diseases, as well as pathogen detection. Along with expanding Bio-Rad's portfolio of CFX products, the company also launched cloud-based instrument connectivity and data management system, BR.io.

Consolidating an accurate optical shuttle system and improved thermal performance, the new CFX systems are designed to provide more consistent data than ever. The advanced RT-PCR systems are capable of performing stand-alone operations, which makes them indispensable as life-research tools for diagnostic interventions. The systems show excellent compatibility to ethernet as well as Wi-Fi, and thus enable completely wireless operations and data management. The user can transfer the retrieved data by connecting the CFX systems with a PC or via direct data transfer to a USB device. In network-connected locations, the CFX Opus system can be programmed to send the data as well notifications directly to your email or local drive, and thus the updated systems deliver an efficient experience to RT-PCR users.

Bio-Rad Laboratories' CFX Opus 96 has five color detection formats whereas CFX Opus 384 RT-PCR provides four color detection formats. The sensitive and modern touchscreen of the systems is responsive even with double gloves and more intuitive than previous generation CFX systems. However, the uniform optical system does not have regular calibration requirements, which saves time and effort. Additionally, the products' block design delivers tight thermal uniformity during the real-time PCR experiments.

Shuttle Optics Technology The newly launched CFX Opus systems retain many features of the previous generation models that researchers and scientists liked. Both the systems have been built upon the same proprietary optical design, employed across the company's portfolio of CFX products, however, the latest ones are easy to set up and install due to improved capabilities and flexible connectivity options. The device manufacturer has put efforts in making the design of the CFX system sleek and modernized, for which they have transcended from a clamshell lid to a retracting version, which allows the RT-PCR to be used in even more spaces than before. Despite the design modifications, the updated system looks somewhat familiar to previous systems, but they are more convenient.

The CXR Opus systems incorporate shuttle optics technology that utilizes the same excitation-detector pair just like other systems in the Bio-Rad's RT-PCR portfolio. In the new systems, shuttling the optics across the plate eliminates the possibility of variability that may result from detectors. Besides, the technology reduces the need for correction in detector angle arising from a single fixed camera. The consistency of the device is further augmented with the significant development in thermal performance, which provides uniformity of ±0.3⁰C and accuracy of ±0.2⁰C. Both the shuttle optics technology and the high-performance thermal gradient work brilliantly together and produce consistent and reliable results.

CFX Maestro Software The CFX systems come with an updated and full-featured CFX Maestro Software, that is easy to use and learn. The software allows users the ability to perform statistical analyses of gene expressions and find solutions to complex biological questions. Also, the user can make an analysis without exporting the retrieved data into a PC with the help of Maestro Software. The software also consists of a Laboratory Information Management System (LIMS) integration, application programming interface (API), and other functions for more advanced users.

BR.io Cloud Platform Bio-Rad Laboratories has expanded the family of life science tools with the addition of the BR.io cloud platform, which provides users a simplified qPCR experience. The cloud connectivity platform incorporates in CRX Opus systems provides a robust solution to meet the needs of the customers in the expanding field of genomics research and diagnostics. Leveraging BR.io, the users can retrieve remote data with any internet-connected computer as well as monitor registered instrument status, thus the cloud connectivity ensures efficiency and provides enhanced versatility in operations. You can connect to the CFX Opus systems to the BR.io cloud platform through an Ethernet connection or with simple Wi-Fi connectivity and access local network file drives for which your institution has granted access. Thus, BR.io provides seamless data transfer, enable users to access data anywhere from the cloud, design experiments, and analyse data.

Latest Additions in RT-PCR systems Azure Cielo 3 Real Time qPCR System Launched in June 2020, the Azure Cielo real-time PCR system is a 96-well qPCR machine dedicated to genomics workflow. The new RT-PCR system delivers a high-performance and provides intuitive workflow due to its innovative optical design. The device assures sensitivity and reproducibility with optimal excitation reaction utilizing single-well excitation and emission. The system features a 10.3" touch screen interface that makes setting up and checking status easy. Data from the compact device can be retrieved via USB, ethernet, or Wi-Fi in a connected environment. The RT-PCR device comes with Azure Cielo Manager software that offers a comprehensive workflow solution and enables accurate analysis. Azure Cielo qPCR is a user-friendly and precise instrument that generates good reproducibility and enhances the productivity of researchers by automating sample extraction, amplification, and detection in one cartridge.

Palm PCR S1 Ahram Biosystem has developed an ultra-fast mobile real-time PCR system that allows one to instantly complete PCR tests anywhere and anytime without any electricity, or communication. A brilliant innovation in RT-PCR systems, the Palm PCR S1 is considered the future of biotechnology. The mobile device is extremely efficient and convenient, which can deliver results in less than 12 minutes with high accuracy even with a single copy target concentration. Powered with convection PCR technology, the ultra-fast system has a maximum of six real-time channels available, thus the full capacity of the device can be achieved without detectable crosstalk. The standalone device consists of a lithium battery that enables four hours of continuous operation and can be operated at temperatures up to 40 degrees Celsius. The device can be easily connected with a PC via Bluetooth and Wi-Fi.

Conclusion Recognizing the importance of molecular diagnostics for the detection of pathogens responsible for infectious diseases, many biotech companies are coming up with innovative RT-PCR systems. Standardization and quality control have remained some of the major limitations of diagnostic PCR, but the new methodologies and technologies are utilizing artificial intelligence to reduce the need for human input. PCR diagnosis is likely to have a huge impact on the customization of healthcare and the development of drugs in the coming years.

According to TechSci Research report on "Global dPCR and qPCR Products Market By Technology (Quantitative, Digital), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing, Others), Research, Forensic, Others), By End User (Hospitals and Diagnostic Center, Research Laboratories and Academic Institute, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), By Region, Forecast & Opportunities, 2025", the global dPCR and qPCR market is estimated to register a significant CAGR owing to rising incidences of infectious diseases as well as increasing application of biomarker profiling for disease diagnostics. Moreover, introduction of technological advancements in PCR technologies and high costs of advanced PCR devices might hinder the growth of dPCR and qPCR market.

According to another TechSci Research report on "Global Real Time PCR Market By Product (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing), Research, Forensic, Others), By End-user (Hospitals & Diagnostic Labs, Research Laboratories & Academic Institutes, Pharma-Biotech, Clinical Research Organizations (CRO), Forensic Laboratories, Others), By Region, Competition, Forecast & Opportunities, 2025", the global real-time PCR market is expected to grow significantly due to increasing advancements in PCR techniques and introduction of funds and grants by government and healthcare organizations across the globe.

[techsciresearch]

Product Review: Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 | TechSci Research

The application of a real-time Polymerase chain reaction (PCR) system in the field of molecular diagnostics has become a standard method for identifying nucleic acids from collected microbial samples. The real-time PCR (also known as RT-PCR) systems are sensitive, rapid, precise, and minimize the risk of contamination while being employed for various research procedures such as detection and expression analysis of genes, quantitative genotyping, early diagnosis of diseases, forensics, etc. Ever since the introduction of RT-PCR, the technology is just getting better with each medical innovation. The COVID-19 pandemic has put RT-PCR in the spotlight as it is considered the most accurate and efficient testing method for the detection of the SARS-CoV-2 virus. The use of RT-PCRs has been tremendously expanding for the testing of novel coronavirus and the demand is likely to grow due to the rising incidences of infectious diseases.

Recently, Bio-Rad Laboratories introduced the next generation of the company's CFX real-time PCR systems, CFX Opus 96 and CFX Opus 384, that offers improved connectivity and high performance. The sleek and modern CFX systems bring forth the next revolution in qPCR with their easy-to-use interface and advanced connectivity options. Both the RT-PCR systems are ideal for basic and translational research, genomic testing, quality control, process development, detecting infectious diseases, as well as pathogen detection. Along with expanding Bio-Rad's portfolio of CFX products, the company also launched cloud-based instrument connectivity and data management system, BR.io.

Consolidating an accurate optical shuttle system and improved thermal performance, the new CFX systems are designed to provide more consistent data than ever. The advanced RT-PCR systems are capable of performing stand-alone operations, which makes them indispensable as life-research tools for diagnostic interventions. The systems show excellent compatibility to ethernet as well as Wi-Fi, and thus enable completely wireless operations and data management. The user can transfer the retrieved data by connecting the CFX systems with a PC or via direct data transfer to a USB device. In network-connected locations, the CFX Opus system can be programmed to send the data as well notifications directly to your email or local drive, and thus the updated systems deliver an efficient experience to RT-PCR users.

Bio-Rad Laboratories' CFX Opus 96 has five color detection formats whereas CFX Opus 384 RT-PCR provides four color detection formats. The sensitive and modern touchscreen of the systems is responsive even with double gloves and more intuitive than previous generation CFX systems. However, the uniform optical system does not have regular calibration requirements, which saves time and effort. Additionally, the products' block design delivers tight thermal uniformity during the real-time PCR experiments.

Shuttle Optics Technology The newly launched CFX Opus systems retain many features of the previous generation models that researchers and scientists liked. Both the systems have been built upon the same proprietary optical design, employed across the company's portfolio of CFX products, however, the latest ones are easy to set up and install due to improved capabilities and flexible connectivity options. The device manufacturer has put efforts in making the design of the CFX system sleek and modernized, for which they have transcended from a clamshell lid to a retracting version, which allows the RT-PCR to be used in even more spaces than before. Despite the design modifications, the updated system looks somewhat familiar to previous systems, but they are more convenient.

The CXR Opus systems incorporate shuttle optics technology that utilizes the same excitation-detector pair just like other systems in the Bio-Rad's RT-PCR portfolio. In the new systems, shuttling the optics across the plate eliminates the possibility of variability that may result from detectors. Besides, the technology reduces the need for correction in detector angle arising from a single fixed camera. The consistency of the device is further augmented with the significant development in thermal performance, which provides uniformity of ±0.3⁰C and accuracy of ±0.2⁰C. Both the shuttle optics technology and the high-performance thermal gradient work brilliantly together and produce consistent and reliable results.

CFX Maestro Software The CFX systems come with an updated and full-featured CFX Maestro Software, that is easy to use and learn. The software allows users the ability to perform statistical analyses of gene expressions and find solutions to complex biological questions. Also, the user can make an analysis without exporting the retrieved data into a PC with the help of Maestro Software. The software also consists of a Laboratory Information Management System (LIMS) integration, application programming interface (API), and other functions for more advanced users.

BR.io Cloud Platform Bio-Rad Laboratories has expanded the family of life science tools with the addition of the BR.io cloud platform, which provides users a simplified qPCR experience. The cloud connectivity platform incorporates in CRX Opus systems provides a robust solution to meet the needs of the customers in the expanding field of genomics research and diagnostics. Leveraging BR.io, the users can retrieve remote data with any internet-connected computer as well as monitor registered instrument status, thus the cloud connectivity ensures efficiency and provides enhanced versatility in operations. You can connect to the CFX Opus systems to the BR.io cloud platform through an Ethernet connection or with simple Wi-Fi connectivity and access local network file drives for which your institution has granted access. Thus, BR.io provides seamless data transfer, enable users to access data anywhere from the cloud, design experiments, and analyse data.

Latest Additions in RT-PCR systems Azure Cielo 3 Real Time qPCR System Launched in June 2020, the Azure Cielo real-time PCR system is a 96-well qPCR machine dedicated to genomics workflow. The new RT-PCR system delivers a high-performance and provides intuitive workflow due to its innovative optical design. The device assures sensitivity and reproducibility with optimal excitation reaction utilizing single-well excitation and emission. The system features a 10.3" touch screen interface that makes setting up and checking status easy. Data from the compact device can be retrieved via USB, ethernet, or Wi-Fi in a connected environment. The RT-PCR device comes with Azure Cielo Manager software that offers a comprehensive workflow solution and enables accurate analysis. Azure Cielo qPCR is a user-friendly and precise instrument that generates good reproducibility and enhances the productivity of researchers by automating sample extraction, amplification, and detection in one cartridge.

Palm PCR S1 Ahram Biosystem has developed an ultra-fast mobile real-time PCR system that allows one to instantly complete PCR tests anywhere and anytime without any electricity, or communication. A brilliant innovation in RT-PCR systems, the Palm PCR S1 is considered the future of biotechnology. The mobile device is extremely efficient and convenient, which can deliver results in less than 12 minutes with high accuracy even with a single copy target concentration. Powered with convection PCR technology, the ultra-fast system has a maximum of six real-time channels available, thus the full capacity of the device can be achieved without detectable crosstalk. The standalone device consists of a lithium battery that enables four hours of continuous operation and can be operated at temperatures up to 40 degrees Celsius. The device can be easily connected with a PC via Bluetooth and Wi-Fi.

Conclusion Recognizing the importance of molecular diagnostics for the detection of pathogens responsible for infectious diseases, many biotech companies are coming up with innovative RT-PCR systems. Standardization and quality control have remained some of the major limitations of diagnostic PCR, but the new methodologies and technologies are utilizing artificial intelligence to reduce the need for human input. PCR diagnosis is likely to have a huge impact on the customization of healthcare and the development of drugs in the coming years.

According to TechSci Research report on "Global dPCR and qPCR Products Market By Technology (Quantitative, Digital), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing, Others), Research, Forensic, Others), By End User (Hospitals and Diagnostic Center, Research Laboratories and Academic Institute, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), By Region, Forecast & Opportunities, 2025", the global dPCR and qPCR market is estimated to register a significant CAGR owing to rising incidences of infectious diseases as well as increasing application of biomarker profiling for disease diagnostics. Moreover, introduction of technological advancements in PCR technologies and high costs of advanced PCR devices might hinder the growth of dPCR and qPCR market.

According to another TechSci Research report on "Global Real Time PCR Market By Product (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing), Research, Forensic, Others), By End-user (Hospitals & Diagnostic Labs, Research Laboratories & Academic Institutes, Pharma-Biotech, Clinical Research Organizations (CRO), Forensic Laboratories, Others), By Region, Competition, Forecast & Opportunities, 2025", the global real-time PCR market is expected to grow significantly due to increasing advancements in PCR techniques and introduction of funds and grants by government and healthcare organizations across the globe.

[soumyafwr]

https://joyrulez.com/blogs/431307/Digital-PCR-dPCR-and-Real-time-PCR-qPCR-Market-Size

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Analysis and Forecast 2031